Industry consortia & centres

Consortia and industry-funded centres in pharma process, crystallization and continuous manufacturing, and how outsiders can take part.

Why this directory exists

Find consortia that accept outside ideas.
See how non-members can take part, in the organisation’s own words.
Share an early-career idea via the networking form.

Listed from public information; not affiliated with or endorsed by these organizations. No official logos are used (marks on this page are our own monograms). Always confirm on the official page. Where a partner list or an engagement route is not published, we say so. Each card shows the date we checked its official page.

19 organisations · checked 05 Nov 2026 · see also pharma process calls, crystallization calls and industry-funded calls.

Organisations by documented pathway

19 organisations in this directory, grouped by the engagement route published on each official page. These are documented pathways, not an offer of grants. “No public route currently published” means the official pages do not say how outsiders can take part. Each pathway card links to the directory filtered to that engagement type. Marks are our own monograms, not official logos. Listed from public information; not affiliated with or endorsed by these organisations.

View as a table

Pathway	Organisations	What this means
Open to proposals	2	Non-members can submit proposals to the organisation's own calls (in rounds or any time).
Ideas welcome from non-members	7	The official page invites outside organisations to propose ideas or projects, without a fixed call.
Members only	6	Funding or project work is for paying or member organisations.
Collaborate via a member institution	1	Outsiders take part through a researcher at a member or host institution.
Invitation only	1	Participation is by invitation from the organisation or its members; no open application route is published.
No public route currently published	2	The official pages do not publish how outsiders can take part.

Engagement labels

Open to proposals
Ideas welcome from non-members
Members only
Collaborate via a member institution
Invitation only
No public route currently published

What the labels mean

Recently checked 8 organisations on 05 Nov 2026; 11 organisations on 30 Oct 2026. The newest check date is 05 Nov 2026. Always confirm on the official page.

What the engagement labels mean

Open to proposalsNon-members can submit proposals to the organisation's own calls (in rounds or any time).
Ideas welcome from non-membersThe official page invites outside organisations to propose ideas or projects, without a fixed call.
Members onlyFunding or project work is for paying or member organisations.
Collaborate via a member institutionOutsiders take part through a researcher at a member or host institution.
Invitation onlyParticipation is by invitation from the organisation or its members; no open application route is published.
No public route currently publishedThe official pages do not publish how outsiders can take part.

For early-career researchers

This is not a recommendation of one consortium. Use the documented non-member routes in the entry map above (open to proposals, ideas welcome, or via a member institution). “Ideas welcome” is typically for outside organisations, not a personal fellowship.

Named training or PhD routes on this site (with their current status)

Rinn Pharma & Biopharma (ex-SSPC) PhD positions (open, rolling / any time)
CMAC CEDAR EPSRC CDT PhD studentships (medicines manufacturing) (Closed; on the calendar, not open now)
NIIMBL Faculty Fellows (faculty sabbatical in biopharmaceutical industry) (Members only; on the calendar, not open now)

To share a research idea yourself, use the networking form below — not a guarantee of an introduction.

Start here: pick a theme

Continuous crystallization2 sourced items1 consortium, 1 playbook Polymorph and solid form control4 sourced items2 consortia, 2 playbooks Impurity rejection and purification2 sourced items1 consortium, 1 playbook Particle engineering7 sourced items3 consortia, 1 playbook, 1 call, 1 company page, 1 calendar item PAT and process modelling (incl. AI/ML-assisted process development)7 sourced items1 consortium, 1 playbook, 2 calls, 3 company pages Flow chemistry4 sourced items1 consortium, 1 call, 2 company pages Biocatalysis2 sourced items2 company pages Green and sustainable process15 sourced items5 consortia, 1 playbook, 2 calls, 5 company pages, 2 calendar items Microgravity crystallization1 sourced item1 call Continuous manufacturing9 sourced items5 consortia, 2 playbooks, 2 company pages

Counts are sourced items (consortia, playbooks, calls, company pages and calendar entries), not a count of consortia only. Suggested starting points, not a ranking.

Step by step from a theme to consortia, playbooks and calls: Start-here guide.

Browse by company View all playbooks Investment groups See industry-funded calls Industry events

Have an idea, need to network? Tell us Early-career researchers: share a research idea and who you’d like to reach. We read every submission; it’s not a guarantee of an introduction.

Filter organisations

Organisations

Enabling Technologies Consortium (ETC)

Founded by the pharmaceutical industry to collaborate with third parties from the vendor and academic…

Key route Two routes for non-members: respond to an open ETC RFI/RFP, or submit a project idea at any time with the…

Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Key route (full) Two routes for non-members: respond to an open ETC RFI/RFP, or submit a project idea at any time with the form on “Collaborate with ETC” (submissions are shared with ETC staff and members; ETC makes no confidentiality commitment). Company membership is for firms sponsoring at least one active Clinical Trial Application for a new chemical or molecular entity: US$30,000 a year plus at least US$20,000 a year towards project fees.

Ideas welcome from non-members

Pharmaceutical and biotechnology companies (industry consortium, formed 2016) · International

pharma process

What it funds or does

Founded by the pharmaceutical industry to collaborate with third parties from the vendor and academic communities to develop or improve pre-competitive enabling technologies for pharmaceutical development and manufacturing. Member companies fund shared projects with external collaborators (the site states $7.4M+ invested in projects).

How an outsider can engage

Ideas welcome from non-membersTwo routes for non-members: respond to an open ETC RFI/RFP, or submit a project idea at any time with the form on “Collaborate with ETC” (submissions are shared with ETC staff and members; ETC makes no confidentiality commitment). Company membership is for firms sponsoring at least one active Clinical Trial Application for a new chemical or molecular entity: US$30,000 a year plus at least US$20,000 a year towards project fees.

Access (from the official pages)

Membership cost: Company membership: US$30,000 a year plus at least US$20,000 a year towards project fees (as stated on the Collaborate / About pages).
Barriers: Company membership is for firms sponsoring at least one active Clinical Trial Application for a new chemical or molecular entity.
Outsider route: Non-members can respond to open ETC RFI/RFPs or submit a project idea via the Collaborate with ETC form (ETC makes no confidentiality commitment).

Current RFIs / RFPs

Enabling Technologies Consortium (ETC) RFI/RFPs and third-party project proposals (open, rolling / any time)

No RFI/RFP is open on 30 Oct 2026; the three 2026 RFPs closed on 17 Jul, 28 Aug and 28 Aug 2026.

Industry partners: 17 listed

ETC Members, exactly as on the official page, as of 30 Oct 2026.

AbbVie
Amgen
Astellas Pharma
AstraZeneca
Biogen
Boehringer Ingelheim
Bristol Myers Squibb
Eli Lilly
Genentech/Roche
Gilead
GSK
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Takeda
Zoetis

Official page · Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Playbooks: Engaging ETC · Pitching precompetitive work

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

A membership institute working to revolutionize biopharmaceutical manufacturing platforms, processes and…

Key route Project Call 10.1 is at an invitation-only stage, and the Faculty Fellows programme is for faculty or staff…

Checked 30 Oct 2026

Key route (full) Project Call 10.1 is at an invitation-only stage, and the Faculty Fellows programme is for faculty or staff at member institutions. Organisations can apply to join through “Join NIIMBL”; anyone can subscribe to the mailing list.

Members only

Member organisations; based in Newark, Delaware · United States

biopharma manufacturingpharma process

What it funds or does

A membership institute working to revolutionize biopharmaceutical manufacturing platforms, processes and educational programs. Members take part in NIIMBL-led programs and technical innovation projects, talent-development projects and member-exclusive events.

How an outsider can engage

Members onlyProject Call 10.1 is at an invitation-only stage, and the Faculty Fellows programme is for faculty or staff at member institutions. Organisations can apply to join through “Join NIIMBL”; anyone can subscribe to the mailing list.

Current RFIs / RFPs

NIIMBL Project Call 10.1 (biopharmaceutical manufacturing technology & workforce) (Invitation-only stage; on the calendar, not open now)
NIIMBL Faculty Fellows (faculty sabbatical in biopharmaceutical industry) (Members only; on the calendar, not open now)

Industry partners

Combined member list (not split by sector; not reproduced). The membership page publishes one combined list of current member organisations (companies, universities, community colleges and associations together). It is not split by sector, so we do not reproduce it or pick out companies; see the official page. Official page.

Official page · Checked 30 Oct 2026

Themes: Continuous manufacturing

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

ACS Green Chemistry Institute Pharmaceutical Roundtable (GCIPR)

Member companies collaborate on green chemistry and engineering in drug discovery and production.

Key route Research grants (Key Research Area and Ignition grants) take proposals in announced rounds; they are between…

Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Key route (full) Research grants (Key Research Area and Ignition grants) take proposals in announced rounds; they are between rounds now. Company membership: annual fees of $12,500–$31,250 for Members and $6,250–$25,000 for Associate and Affiliate Members, depending on company sales.

Open to proposals

American Chemical Society Green Chemistry Institute; member companies · International

pharma processgreen chemistrycontinuous flow

What it funds or does

Member companies collaborate on green chemistry and engineering in drug discovery and production. The Roundtable states it has awarded over $4 million in funding to further key research priorities for greener chemistries, and develops shared tools (solvent selection, PMI calculators, reagent guides).

How an outsider can engage

Open to proposalsResearch grants (Key Research Area and Ignition grants) take proposals in announced rounds; they are between rounds now. Company membership: annual fees of $12,500–$31,250 for Members and $6,250–$25,000 for Associate and Affiliate Members, depending on company sales.

Access (from the official pages)

Membership cost: Annual fees of $12,500–$31,250 for Members and $6,250–$25,000 for Associate and Affiliate Members, depending on company sales (membership page).
Barriers: Company membership fees scale with sales; research grants are between announced rounds.
Outsider route: Key Research Area and Ignition research grants take proposals in announced rounds.

Current RFIs / RFPs

ACS GCI Pharmaceutical Roundtable Key Research Area Grants (Between rounds; on the calendar, not open now)
ACS GCI Pharmaceutical Roundtable Ignition Grants (Between rounds; on the calendar, not open now)

The most recent open call, the High or Medium Throughput Biodegradation Determination Development Challenge (funding up to $130,000), closed on 25 Sep 2026.

Industry partners

Shown as logos on their site. Not transcribed.

Official page · Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Playbook: Pitching precompetitive work

Themes: Green and sustainable process

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

CMAC (Continuous Manufacturing and Advanced Crystallisation)

A medicines manufacturing research centre led by the University of Strathclyde: industrially relevant…

Key route Organisations can contact CMAC's industry team.

Checked 30 Oct 2026

Key route (full) Organisations can contact CMAC's industry team. Knowledge Transfer Partnerships are open to all organisations whose work aligns with CMAC's research focus; the National Facility offers fee-for-use access to labs and expertise. Core Projects are an exclusive benefit for Tier One Industry Partners.

Ideas welcome from non-members

University of Strathclyde (Glasgow), with academic and industry partners · United Kingdom

crystallizationcontinuous manufacturingpharma process

What it funds or does

A medicines manufacturing research centre led by the University of Strathclyde: industrially relevant research, PhD and MSc training, and continuous-processing, process-analysis and characterisation facilities. Its Core Projects are collaborative, pre-competitive research funded by Tier One partners.

How an outsider can engage

Ideas welcome from non-membersOrganisations can contact CMAC's industry team. Knowledge Transfer Partnerships are open to all organisations whose work aligns with CMAC's research focus; the National Facility offers fee-for-use access to labs and expertise. Core Projects are an exclusive benefit for Tier One Industry Partners.

Current RFIs / RFPs

CMAC CEDAR EPSRC CDT PhD studentships (medicines manufacturing) (Closed; on the calendar, not open now)

Industry partners

Shown as logos on their site. Tier One, Translation to Industry, Tier Two, academic and strategic partners; not transcribed.

Official page · Checked 30 Oct 2026

Playbooks: Working through a center · Published examples

Themes: Continuous crystallization · Continuous manufacturing

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

SSPC, the Research Ireland Centre for Pharmaceuticals

Collaborative industry–academic research across small- and large-molecule drug substance and drug product…

Key route Companies can initiate fully funded, industry-specific research projects and own all project IP, or use SSPC…

Checked 30 Oct 2026

Key route (full) Companies can initiate fully funded, industry-specific research projects and own all project IP, or use SSPC co-funding (max. 50%) with the option to license back IP. SSPC also runs an industry membership model (training, PhD placements, networking). Contact the Business Development team listed on the page.

Ideas welcome from non-members

Bernal Institute, University of Limerick, with Irish partner institutions · Ireland

pharma processcrystallizationbiopharma manufacturing

What it funds or does

Collaborative industry–academic research across small- and large-molecule drug substance and drug product manufacturing, with an emphasis on process optimisation, data analytics and ATMPs. SSPC says it has collaborated with over 51 industry partners.

How an outsider can engage

Ideas welcome from non-membersCompanies can initiate fully funded, industry-specific research projects and own all project IP, or use SSPC co-funding (max. 50%) with the option to license back IP. SSPC also runs an industry membership model (training, PhD placements, networking). Contact the Business Development team listed on the page.

Current RFIs / RFPs

SSPC/Rinn industry-led research projects (fully funded or up to 50% co-funding) (open, rolling / any time)
Rinn Pharma & Biopharma (ex-SSPC) PhD positions (open, rolling / any time)

Industry partners

Shown as logos on their site. Not transcribed.

Official page · Checked 30 Oct 2026

Playbooks: Working through a center · Published examples

Themes: Green and sustainable process

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Young Institute Pharmaceutical Manufacturing Consortium (Purdue)

An academic–industry consortium spearheaded by the Young Institute, focused on sterile injectables and…

Key route How outside organisations join or propose work is not published on the institute's pages.

Checked 30 Oct 2026

Key route (full) How outside organisations join or propose work is not published on the institute's pages. The institute lists a general contact address (younginstitute@purdue.edu).

No public route currently published

William D. and Sherry L. Young Institute for the Advanced Manufacturing of Pharmaceuticals, Purdue University · United States

pharma processsterile / aseptic manufacturing

What it funds or does

An academic–industry consortium spearheaded by the Young Institute, focused on sterile injectables and innovative aseptic manufacturing technology.

How an outsider can engage

No public route currently publishedHow outside organisations join or propose work is not published on the institute's pages. The institute lists a general contact address (younginstitute@purdue.edu).

Current RFIs / RFPs

None on this site right now.

Industry partners: 2 listed

Named as consortium collaborators, exactly as on the official page, as of 30 Oct 2026.

Eli Lilly and Company
Merck

The page names these two collaborators; no full member list is published.

Official page · Checked 30 Oct 2026

Playbook: Working through a center

Themes: Continuous manufacturing

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Eli Lilly and Company and Purdue University Research Alliance Center (LPRC)

A Lilly–Purdue research alliance: a formal strategic research collaboration plus exploration of aligned…

Key route Through Purdue: the trustees' memo describes a membership program for faculty on Purdue's West Lafayette and…

Checked 30 Oct 2026

Key route (full) Through Purdue: the trustees' memo describes a membership program for faculty on Purdue's West Lafayette and Indianapolis campuses. No route for outside organisations is published.

Collaborate via a member institution

Purdue University · United States

drug delivery

What it funds or does

A Lilly–Purdue research alliance: a formal strategic research collaboration plus exploration of aligned research areas (genetic medicine, intrathecal delivery and nanoparticle delivery). A June 2026 Purdue Board of Trustees memo requests renaming it the Lilly Purdue Innovation Institute.

How an outsider can engage

Collaborate via a member institutionThrough Purdue: the trustees' memo describes a membership program for faculty on Purdue's West Lafayette and Indianapolis campuses. No route for outside organisations is published.

Current RFIs / RFPs

None on this site right now.

Industry partners: 1 listed

Named in the centre's title, exactly as on the official page, as of 30 Oct 2026.

Eli Lilly and Company

Official page · Checked 30 Oct 2026

lprc.research.purdue.edu refuses automated requests (HTTP 403), so this entry was checked on the Young Institute research page and a June 2026 Purdue Board of Trustees memo (purdue.edu).

Playbook: Working through a center

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

PharmaSEL-Prosperity Partnership (Imperial College London / UCL)

A business-led research programme led by Eli Lilly and Company and the Sargent Centre for Process Systems…

Key route Not published.

Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Key route (full) Not published. The programme page does not give a route for outside researchers or companies to take part.

No public route currently published

Sargent Centre for Process Systems Engineering, Imperial College London and UCL · United Kingdom

crystallizationpharma processprocess systems engineering

What it funds or does

A business-led research programme led by Eli Lilly and Company and the Sargent Centre for Process Systems Engineering, co-funded by Eli Lilly and Company and EPSRC (Prosperity Partnership). Themes: drug substance crystallisation, synthesis and purification; drug product manufacturing and stability; underpinning systems technologies.

How an outsider can engage

No public route currently publishedNot published. The programme page does not give a route for outside researchers or companies to take part.

Current RFIs / RFPs

None on this site right now.

Industry partners: 1 listed

Named on the programme page, exactly as on the official page, as of 30 Oct 2026.

Eli Lilly and Company

Official page · Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Playbook: Published examples

Themes: Impurity rejection and purification

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Center for Structured Organic Particulate Systems (C-SOPS)

Research on the science and engineering of solid dosage forms and their manufacturing processes, including…

Key route Companies join the industrial consortium.

Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Key route (full) Companies join the industrial consortium. The page describes a single membership tier of $50,000 per year (cash and in-kind) from its 2015–16 plan, so current fees may differ; contact the Associate Director named on the page.

Members only

Rutgers University (lead), with NJIT, Purdue University and the University of Puerto Rico at Mayaguez · United States

pharma processcontinuous manufacturingparticle technology

What it funds or does

Research on the science and engineering of solid dosage forms and their manufacturing processes, including continuous manufacturing, run with an industrial consortium in a non/pre-competitive setting.

How an outsider can engage

Members onlyCompanies join the industrial consortium. The page describes a single membership tier of $50,000 per year (cash and in-kind) from its 2015–16 plan, so current fees may differ; contact the Associate Director named on the page.

Access (from the official pages)

Membership cost: The industry-program page describes a single membership tier of $50,000 per year (cash and in-kind) from its 2015–16 plan; current fees may differ — contact the Associate Director named on the page.
Barriers: Companies join the industrial consortium; project work is for members.
Outsider route: Not published beyond joining as a member company.

Current RFIs / RFPs

C-SOPS industry membership / sponsored projects (Members only; on the calendar, not open now)

Industry partners

Not published. The site says “more than 40 industrial consortium member companies” but does not publish their names. Official page.

Official page · Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Playbook: Working through a center

Themes: Particle engineering · Continuous manufacturing

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Medicines Manufacturing Innovation Centre (CPI)

A GMP-regulated medicines manufacturing facility run by CPI as a collaboration with partner organisations…

Key route CPI's pharma page invites companies to get in touch about developing and scaling pharmaceutical innovations…

Checked 30 Oct 2026

Key route (full) CPI's pharma page invites companies to get in touch about developing and scaling pharmaceutical innovations; terms are not published. CPI's dedicated centre page now returns “not found”.

Ideas welcome from non-members

CPI (Innovate UK Catapult Network), Renfrewshire, Scotland · United Kingdom

pharma processdigital manufacturing

What it funds or does

A GMP-regulated medicines manufacturing facility run by CPI as a collaboration with partner organisations from pharma, business, academia and government (24 partners when it opened on 30 Nov 2022), working on industry “Grand Challenges” such as more sustainable manufacturing processes.

How an outsider can engage

Ideas welcome from non-membersCPI's pharma page invites companies to get in touch about developing and scaling pharmaceutical innovations; terms are not published. CPI's dedicated centre page now returns “not found”.

Current RFIs / RFPs

None on this site right now.

Industry partners: 9 listed

Industry partners as announced Nov 2022 (CPI's opening announcement, 30 Nov 2022; no current list is published), exactly as on the official page, as of 30 Oct 2026.

AstraZeneca
GSK
Pfizer
Novartis
Alnylam
PwC
Siemens
Applied Materials
Atos

The announcement also names CPI, the University of Strathclyde, UK Research and Innovation and Scottish Enterprise as founding partners.

Official page · Checked 30 Oct 2026

Themes: Green and sustainable process

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Center for Integrated Material Science and Engineering of Pharmaceutical Products (CIMSEPP), NSF IUCRC

An NSF Industry–University Cooperative Research Center (Phase I) on material properties, drug–additive…

Key route IUCRC members are companies that sign the center's membership agreement, pay the membership fee and vote on…

Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Key route (full) IUCRC members are companies that sign the center's membership agreement, pay the membership fee and vote on research projects at the Industry Advisory Board (NSF's published membership steps). The fee is not published on NSF's page.

Members only

New Jersey Institute of Technology (lead site) and University of Minnesota · United States

crystallizationparticle technologypharma process

What it funds or does

An NSF Industry–University Cooperative Research Center (Phase I) on material properties, drug–additive interactions at molecular and particulate levels, and manufacturing processes; research thrusts include particle and crystal engineering.

How an outsider can engage

Members onlyIUCRC members are companies that sign the center's membership agreement, pay the membership fee and vote on research projects at the Industry Advisory Board (NSF's published membership steps). The fee is not published on NSF's page.

Current RFIs / RFPs

None on this site right now.

Industry partners: 10 listed

Member organizations (as submitted by the Center to NSF), exactly as on the official page, as of 30 Oct 2026.

Alexion
BASF
Boehringer
Bristol Meyers Squibb
Eli Lilly
GlaxoSmithKline
Merck
Novartis Pharma AB
Sanofi
Seran Biosciences

Spelling exactly as on NSF's page.

Official page · Checked 30 Oct 2026 · official pages unchanged as of 12 Nov 2026 (daily recheck)

Playbook: Working through a center

Themes: Particle engineering

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

BioPhorum

Industry collaboration that runs focused Phorums (workstreams) so member companies can share challenges and…

Key route BioPhorum membership is an annual company subscription by individual Phorum(s).

Checked 05 Nov 2026

Key route (full) BioPhorum membership is an annual company subscription by individual Phorum(s). Organisations enquire via the membership form on the official membership page. Dollar fees are not published on that page.

Members only

BioPhorum (industry collaboration; biopharmaceutical and device companies and suppliers) · International

biopharma manufacturingpharma process

What it funds or does

Industry collaboration that runs focused Phorums (workstreams) so member companies can share challenges and develop peer-led best practices across biopharmaceutical development and manufacturing. The site states BioPhorum consists of 12 Phorums directing more than 100 workstreams.

How an outsider can engage

Members onlyBioPhorum membership is an annual company subscription by individual Phorum(s). Organisations enquire via the membership form on the official membership page. Dollar fees are not published on that page.

Access (from the official pages)

Membership cost: Not stated as a public figure on the membership page (annual company subscription by Phorum; enquire via the form).
Barriers: Company subscription; participation in a Phorum is for authorised member-company representatives.
Outsider route: Complete the membership enquiry form on biophorum.com/biophorum-membership/; some publications and tools are described as freely browsable on the site.

Current RFIs / RFPs

None on this site right now.

Industry partners

Not published. The membership page does not publish a text list of current member companies. Official page.

Official page · Checked 05 Nov 2026

Themes: Green and sustainable process

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

IQ Consortium (International Consortium for Innovation and Quality in Pharmaceutical Development)

A technically focused organisation of pharmaceutical and biotechnology companies that collaborates on science…

Key route Any corporation (or subsidiary) significantly engaged in developing new chemical or molecular entities…

Checked 05 Nov 2026

Key route (full) Any corporation (or subsidiary) significantly engaged in developing new chemical or molecular entities — meaning it currently sponsors at least one active Clinical Trial Application for an NCE/NME — is eligible. Contact info@iqconsortium.org to enquire about joining.

Members only

Pharmaceutical and biotechnology member companies · International

pharma process

What it funds or does

A technically focused organisation of pharmaceutical and biotechnology companies that collaborates on science and technology to advance pharmaceutical development. Members lead collaborative research, industry surveys and benchmarking, and share results with scientific and regulatory communities.

How an outsider can engage

Members onlyAny corporation (or subsidiary) significantly engaged in developing new chemical or molecular entities — meaning it currently sponsors at least one active Clinical Trial Application for an NCE/NME — is eligible. Contact info@iqconsortium.org to enquire about joining.

Access (from the official pages)

Membership cost: Not published on the About Us page.
Barriers: Must be significantly engaged in NCE/NME development (at least one active Clinical Trial Application).
Outsider route: Contact info@iqconsortium.org; academics and other groups are described as external collaborators of member-led work, not as a separate open call route on this page.

Current RFIs / RFPs

None on this site right now.

Industry partners: 55 listed

IQ Members (as listed on About Us), exactly as on the official page, as of 05 Nov 2026.

AbbVie
Agios
Alkermes
Alnylam
Amgen, Inc.
Astellas
AstraZeneca
Avidity Biosciences
Bayer HealthCare
BeOne Medicines
Bill & Melinda Gates MRI
Biogen
BioMarin
Blueprint Medicines
Boehringer Ingelheim
Bristol Myers Squibb
Callio Therapeutics
Crinetics Pharmaceuticals
CSL Behring
Daiichi Sankyo
Eisai, Inc.
Eli Lilly and Company
EMD Serono
Erasca, Inc.
Exelixis, Inc.
F. Hoffmann-La Roche
Genentech
Gilead Sciences
GSK
IDEAYA Biosciences
Incyte Corporation
Johnson & Johnson
Kura Oncology
Kymera Therapeutics
Merck & Co., Inc.
Mitsubishi Tanabe
Moderna Therapeutics
Novartis
Novo Nordisk
Organon
Orion Pharma
Otsuka
Pfizer, Inc.
Regeneron
Relay Therapeutics
Sanofi
Sarepta
Servier
Sironax USA
Takeda
Teva
UCB Pharma
Vertex, Inc.
Xencor
Zoetis

Official page · Checked 05 Nov 2026

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Pistoia Alliance

A global non-profit community of more than 200 member organisations across the biopharmaceutical ecosystem…

Key route Anybody can become a member (pharma, vendors, academics, patient groups).

Checked 05 Nov 2026

Key route (full) Anybody can become a member (pharma, vendors, academics, patient groups). The site also has a “Submit an Idea” route for project ideas. Not-for-profit and academic rates are available on application.

Ideas welcome from non-members

Pistoia Alliance (non-profit; biopharma R&D ecosystem members) · International

pharma process

What it funds or does

A global non-profit community of more than 200 member organisations across the biopharmaceutical ecosystem that collaborates on shared R&D informatics and data problems, projects and communities.

How an outsider can engage

Ideas welcome from non-membersAnybody can become a member (pharma, vendors, academics, patient groups). The site also has a “Submit an Idea” route for project ideas. Not-for-profit and academic rates are available on application.

Access (from the official pages)

Membership cost: Entry Level $8,400 p.a.; Small $21,000; Medium $31,500; Large $63,000 (2026 fees on the membership page). From 1 Jan 2027: Academic/NFP $1,600; Entry $8,652; Small $21,630; Medium $32,445; Large $64,890.
Barriers: Fee tier based on annual sales and/or R&D spend; Academic and NFP rates on application.
Outsider route: Become a Member form on the membership page; Submit an Idea for project ideas; some events and training are described separately.

Current RFIs / RFPs

None on this site right now.

Industry partners

Not published. The membership page states “Our 200 members” but does not publish a text list of names on that page. Official page.

Official page · Checked 05 Nov 2026

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Crystal Form Consortium (CCDC)

An industry-led consortium (established 2009) in which development chemists from member pharmaceutical…

Key route The public pages describe CFC as a collaboration of member companies with CCDC; they do not publish an open…

Checked 05 Nov 2026

Key route (full) The public pages describe CFC as a collaboration of member companies with CCDC; they do not publish an open application form for new company members. Contact hello@ccdc.cam.ac.uk or the contact form for demos and further discussion.

Invitation only

Cambridge Crystallographic Data Centre (CCDC), with pharmaceutical company members · International

crystallizationpharma process

What it funds or does

An industry-led consortium (established 2009) in which development chemists from member pharmaceutical companies work with CCDC scientists on structural-informatics tools for solid-form risk assessment; tools are released in the CSD-Materials suite. CCDC’s July 2024 post states the CFC has 12 members including leading biopharmaceutical companies and the CCDC.

How an outsider can engage

Invitation onlyThe public pages describe CFC as a collaboration of member companies with CCDC; they do not publish an open application form for new company members. Contact hello@ccdc.cam.ac.uk or the contact form for demos and further discussion.

Access (from the official pages)

Membership cost: Not published on the CFC pages we checked.
Barriers: Industry-led consortium; no public join form found on the pages checked today.
Outsider route: Not published as an open route; CCDC invites contact for demos (hello@ccdc.cam.ac.uk). CSD software licensing is a separate product path on ccdc.cam.ac.uk.

Current RFIs / RFPs

None on this site right now.

Industry partners

Shown as logos on their site. The July 2024 post shows “List of current Crystal Form Consortium members” as an image; names are not transcribed.

Official page · Checked 05 Nov 2026

Themes: Polymorph and solid form control

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

National Institute for Pharmaceutical Technology & Education (NIPTE)

A consortium of top universities advancing pharmaceutical science, technology and manufacturing, including…

Key route The Industry–NIPTE Partnership page says NIPTE is seeking industrial partners for the Advisory Council on…

Checked 05 Nov 2026

Key route (full) The Industry–NIPTE Partnership page says NIPTE is seeking industrial partners for the Advisory Council on Industry Relations. Faculty at member universities can join the Faculty Committee after nomination by their department head. General community newsletter signup is open to everyone.

Ideas welcome from non-members

Consortium of member universities (led from Minneapolis, MN) · United States

pharma processcontinuous manufacturing

What it funds or does

A consortium of top universities advancing pharmaceutical science, technology and manufacturing, including continuous manufacturing and AI-enabled manufacturing. It runs an Advisory Council on Industry Relations as a gateway for companies seeking academic expertise across the NIPTE network, and describes a NIPTE Consulting Consortium for industry projects.

How an outsider can engage

Ideas welcome from non-membersThe Industry–NIPTE Partnership page says NIPTE is seeking industrial partners for the Advisory Council on Industry Relations. Faculty at member universities can join the Faculty Committee after nomination by their department head. General community newsletter signup is open to everyone.

Access (from the official pages)

Membership cost: Not published on the membership or industry-partnership pages checked today.
Barriers: Faculty Committee requires nomination by a department head at a NIPTE member organisation.
Outsider route: Companies: contact via the Industry–NIPTE Partnership / Contact Us pages. Individuals: join the general NIPTE Community for the newsletter.

Current RFIs / RFPs

None on this site right now.

Industry partners: 17 listed

NIPTE member universities (as listed on Membership), exactly as on the official page, as of 05 Nov 2026.

Duquesne University
Illinois Institute of Technology
Long Island University
Purdue University
Rutgers University
Texas A&M University
University of Connecticut
University of Iowa
University of Kansas
University of Maryland
University of Michigan
University of Minnesota
University of Mississippi
University of Puerto Rico
University of Rochester
Virginia Commonwealth University
Indian Institute of Technology, Delhi (affiliate member)

These are university members, not industry partners. Industry partners for the Advisory Council are not listed as text on the pages checked.

Official page · Checked 05 Nov 2026

Themes: PAT and process modelling (incl. AI/ML-assisted process development) · Continuous manufacturing

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Innovative Health Initiative (IHI)

An EU public–private partnership funding collaborative health research and innovation across pharmaceuticals…

Key route Organisations apply to published IHI calls for proposals (single-stage or two-stage).

Checked 05 Nov 2026

Key route (full) Organisations apply to published IHI calls for proposals (single-stage or two-stage). Draft topic texts are published ahead of launch. There is also a route to propose ideas and to become a contributing partner.

Open to proposals

EU public–private partnership (European Commission and COCIR, EFPIA/Vaccines Europe, EuropaBio, MedTech Europe) · European Union / Horizon Europe associated countries

pharma processbiopharma manufacturing

What it funds or does

An EU public–private partnership funding collaborative health research and innovation across pharmaceuticals, biotechnology, medical technology and data. Total budget for 2021–2027 is stated as €2.4 billion (€1.2bn Horizon Europe; €1bn industry partners; €200m other contributing partners).

How an outsider can engage

Open to proposalsOrganisations apply to published IHI calls for proposals (single-stage or two-stage). Draft topic texts are published ahead of launch. There is also a route to propose ideas and to become a contributing partner.

Access (from the official pages)

Membership cost: Not a company membership fee model for applicants; IHI is funded jointly by the EU and industry associations (see funding-model page).
Barriers: Calls are collaborative; applicants form consortia. Eligibility follows each call’s rules and Horizon Europe conditions.
Outsider route: Apply via open calls on ihi.europa.eu/apply-funding; propose ideas / become a contributing partner via the Shape our future research pages.

Current RFIs / RFPs

None on this site right now.

Industry partners: 4 listed

Industry association partners named on the funding-model page, exactly as on the official page, as of 05 Nov 2026.

COCIR
EFPIA / Vaccines Europe
EuropaBio
MedTech Europe

Association partners that fund IHI with the EU; individual company project partners vary by call and are not listed here.

Official page · Checked 05 Nov 2026

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Research Center Pharmaceutical Engineering (RCPE)

An independent research centre for pharmaceutical process and product development, from in silico prediction…

Key route The industry page invites partnering: collaborations with and without funding, including COMET projects…

Checked 05 Nov 2026

Key route (full) The industry page invites partnering: collaborations with and without funding, including COMET projects (programme covering up to 50% of research-related costs) and customised service agreements. Contact via the site’s contact pages.

Ideas welcome from non-members

RCPE GmbH, Graz, Austria (COMET Competence Centre) · Austria / International

pharma processcontinuous manufacturingcrystallization

What it funds or does

An independent research centre for pharmaceutical process and product development, from in silico prediction and formulation through to scale-up in a pilot plant. As a COMET centre it runs publicly funded collaborative projects and customised industry service agreements.

How an outsider can engage

Ideas welcome from non-membersThe industry page invites partnering: collaborations with and without funding, including COMET projects (programme covering up to 50% of research-related costs) and customised service agreements. Contact via the site’s contact pages.

Access (from the official pages)

Membership cost: Not published as a flat membership fee on the industry pages checked; COMET projects and service agreements are structured per collaboration.
Barriers: COMET projects must align with RCPE’s research areas; terms of service agreements are not published in full on the page.
Outsider route: Contact RCPE about COMET collaborative projects or fee-for-service work (Analytical Science, Material Science, Pilot Plant services are listed).

Current RFIs / RFPs

None on this site right now.

Industry partners

Not published. The page describes partners from global pharma to SMEs but does not publish a text list of company names. Official page.

Official page · Checked 05 Nov 2026

Themes: Flow chemistry · Green and sustainable process

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Dane O. Kildsig Center for Pharmaceutical Processing Research (CPPR)

An NSF Industry–University Cooperative Research Center devoted to pharmaceutical processing research.

Key route Pharmaceutical and related companies that contribute an annual fee and agree to the sponsorship agreement may…

Checked 05 Nov 2026

Key route (full) Pharmaceutical and related companies that contribute an annual fee and agree to the sponsorship agreement may join through any of the academic partners and become voting IAB members. The annual fee amount is not published on the overview / how-it-operates pages checked today.

Members only

University of Connecticut (lead) and Purdue University (academic partners; I/UCRC) · United States

pharma processparticle technology

What it funds or does

An NSF Industry–University Cooperative Research Center devoted to pharmaceutical processing research. Member companies on the Industrial Advisory Board pool annual funds and vote on faculty projects presented at bi-annual meetings.

How an outsider can engage

Members onlyPharmaceutical and related companies that contribute an annual fee and agree to the sponsorship agreement may join through any of the academic partners and become voting IAB members. The annual fee amount is not published on the overview / how-it-operates pages checked today.

Access (from the official pages)

Membership cost: Not published as a dollar figure on the overview or how-CPPR-operates pages checked today (companies “contribute an annual fee”).
Barriers: Must sign the CPPR sponsorship agreement and pay the annual fee; IAB closed sessions vote on projects.
Outsider route: Join as an IAB member company via an academic partner; no separate open call for non-members is published on these pages.

Current RFIs / RFPs

None on this site right now.

Industry partners

Not published. IAB company names appear in individual news posts but are not consolidated as a current text list on the overview pages; we do not assemble a list from scattered posts. Official page.

Official page · Checked 05 Nov 2026

Themes: Polymorph and solid form control · Particle engineering

Know of a route? Tell us (prefilled suggest form; we check every tip on the official page).

Listed from public information; not affiliated with or endorsed by these organizations.

Documented collaboration examples

Publicly documented collaborations, quoted from the collaboration examples playbook. Not a ranking and not an offer of grants.

Novartis-MIT Center for Continuous Manufacturing
Date: 28 Sep 2007 (announcement)
A 10-year partnership to develop technologies to replace batch-based pharmaceutical production with continuous manufacturing; Novartis was to invest USD 65 million in research at MIT over 10 years. Source
Pfizer joins CMAC as a strategic member
Date: 18 Dec 2017 (press release)
Pfizer joined CMAC (Continuous Manufacturing and Advanced Crystallisation), a pre-competitive consortium led by the University of Strathclyde, as a strategic member; the CMAC Future Manufacturing Research Hub was one of six EPSRC hubs established in 2017. Source

View as a table

All organisations at a glance

Organisation	Focus	Engagement	Key route	Card
ETC	Founded by the pharmaceutical industry to collaborate with third parties from the vendor and academic…	Ideas welcome from non-members	Two routes for non-members: respond to an open ETC RFI/RFP, or submit a project idea at any time with the…	Card for ETC ↓
NIIMBL	A membership institute working to revolutionize biopharmaceutical manufacturing platforms, processes and…	Members only	Project Call 10.1 is at an invitation-only stage, and the Faculty Fellows programme is for faculty or staff…	Card for NIIMBL ↓
ACS GCIPR	Member companies collaborate on green chemistry and engineering in drug discovery and production.	Open to proposals	Research grants (Key Research Area and Ignition grants) take proposals in announced rounds; they are between…	Card for ACS GCIPR ↓
CMAC	A medicines manufacturing research centre led by the University of Strathclyde: industrially relevant…	Ideas welcome from non-members	Organisations can contact CMAC's industry team.	Card for CMAC ↓
SSPC	Collaborative industry–academic research across small- and large-molecule drug substance and drug product…	Ideas welcome from non-members	Companies can initiate fully funded, industry-specific research projects and own all project IP, or use SSPC…	Card for SSPC ↓
Young Institute	An academic–industry consortium spearheaded by the Young Institute, focused on sterile injectables and…	No public route currently published	How outside organisations join or propose work is not published on the institute's pages.	Card for Young Institute ↓
LPRC	A Lilly–Purdue research alliance: a formal strategic research collaboration plus exploration of aligned…	Collaborate via a member institution	Through Purdue: the trustees' memo describes a membership program for faculty on Purdue's West Lafayette and…	Card for LPRC ↓
PharmaSEL	A business-led research programme led by Eli Lilly and Company and the Sargent Centre for Process Systems…	No public route currently published	Not published.	Card for PharmaSEL ↓
C-SOPS	Research on the science and engineering of solid dosage forms and their manufacturing processes, including…	Members only	Companies join the industrial consortium.	Card for C-SOPS ↓
CPI MMIC	A GMP-regulated medicines manufacturing facility run by CPI as a collaboration with partner organisations…	Ideas welcome from non-members	CPI's pharma page invites companies to get in touch about developing and scaling pharmaceutical innovations…	Card for CPI MMIC ↓
CIMSEPP	An NSF Industry–University Cooperative Research Center (Phase I) on material properties, drug–additive…	Members only	IUCRC members are companies that sign the center's membership agreement, pay the membership fee and vote on…	Card for CIMSEPP ↓
BioPhorum	Industry collaboration that runs focused Phorums (workstreams) so member companies can share challenges and…	Members only	BioPhorum membership is an annual company subscription by individual Phorum(s).	Card for BioPhorum ↓
IQ Consortium	A technically focused organisation of pharmaceutical and biotechnology companies that collaborates on science…	Members only	Any corporation (or subsidiary) significantly engaged in developing new chemical or molecular entities…	Card for IQ Consortium ↓
Pistoia Alliance	A global non-profit community of more than 200 member organisations across the biopharmaceutical ecosystem…	Ideas welcome from non-members	Anybody can become a member (pharma, vendors, academics, patient groups).	Card for Pistoia Alliance ↓
CCDC CFC	An industry-led consortium (established 2009) in which development chemists from member pharmaceutical…	Invitation only	The public pages describe CFC as a collaboration of member companies with CCDC; they do not publish an open…	Card for CCDC CFC ↓
NIPTE	A consortium of top universities advancing pharmaceutical science, technology and manufacturing, including…	Ideas welcome from non-members	The Industry–NIPTE Partnership page says NIPTE is seeking industrial partners for the Advisory Council on…	Card for NIPTE ↓
IHI	An EU public–private partnership funding collaborative health research and innovation across pharmaceuticals…	Open to proposals	Organisations apply to published IHI calls for proposals (single-stage or two-stage).	Card for IHI ↓
RCPE	An independent research centre for pharmaceutical process and product development, from in silico prediction…	Ideas welcome from non-members	The industry page invites partnering: collaborations with and without funding, including COMET projects…	Card for RCPE ↓
CPPR	An NSF Industry–University Cooperative Research Center devoted to pharmaceutical processing research.	Members only	Pharmaceutical and related companies that contribute an annual fee and agree to the sponsorship agreement may…	Card for CPPR ↓

Focus and key route are the first sentence of each card’s sourced text; open the card for the full text and sources.

What we can’t list

Many useful routes into industry consortia never appear as open calls. We only list what an official page states. That means we leave out:

Unadvertised mechanisms — programme-officer or member-to-member routes with no public page.
Members-only portals and gated newsletters — we do not scrape login-only content.
Invitation-only stages — when a page says a call is invitation-only, we label it that way; we do not invent how to get an invitation.
Hearsay and logo-only partner lists — partner names appear only when the official page lists them as text; tips are published only after we verify them on an official page.

If you know a public route we missed, use Suggest a call or the per-card “Know of a route? Tell us” link. We check every tip against the funder or consortium page before listing it.

Companies, playbooks, themes and investment groups

Company pathways

Pages on what individual companies state publicly, with sources: AstraZeneca · Eli Lilly and Company · GSK plc · Merck & Co., Inc. · Pfizer Inc. (all company pages).

Playbooks

Short practical guides: Engaging ETC · Lilly LRAP · Working through a center · Pitching precompetitive work · Published examples (all playbooks).

Research themes

Investment groups & corporate VCs

A short, evidence-qualified directory of equity investors with published process, manufacturing or enabling-technology relevance for spin-outs — not a fundraising matching service. 2 groups with direct-fit evidence · informational only; not an endorsement. Separate broader life-science investors list (14) — published life-science investing activity, process fit unconfirmed.

Have an idea, need to network? Tell us Early-career researchers: share a research idea and who you’d like to reach. We read every submission; it’s not a guarantee of an introduction.